US2008154335A1PendingUtilityA1

Portable assemblies, systems and methods for providing functional or therapeutic neuromuscular stimulation

51
Assignee: NDI MEDICAL LLCPriority: Feb 12, 2004Filed: Mar 6, 2008Published: Jun 26, 2008
Est. expiryFeb 12, 2024(expired)· nominal 20-yr term from priority
A61N 1/0558A61N 1/36021A61N 1/36003A61N 1/37211A61N 1/36017
51
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Neuromuscular stimulation assemblies, systems, and methods make possible the providing of short-term therapy or diagnostic testing by providing electrical connections between muscles or nerves inside the body and stimulus generators or recording instruments mounted on the surface of the skin outside the body. Neuromuscular stimulation assemblies, systems, and methods may include a steerable introducer that defines an interior lumen sized and configured to shield a percutaneous electrode from contact with tissue during advancement to a desired position within tissue.

Claims

exact text as granted — not AI-modified
1 . A neuromuscular stimulation assembly comprising
 a carrier sized and configured to be worn by a user, the carrier including a tissue facing surface,   at least one percutaneous electrode extending from the carrier,   circuitry carried on-board the carrier configured to generate a stimulation pulse to the electrode, and   the carrier tissue facing surface including an adhesive region, the adhesive region being in contact with the external skin surface.   
     
     
         2 . A method of evaluating whether a person has an innervated muscle which responds to electrical stimulation comprising
 providing a neuromuscular stimulation assembly comprising a carrier sized and configured to be worn by a user, the carrier including a tissue facing surface, at least one percutaneous electrode extending from the carrier, circuitry carried on-board the carrier configured to generate a stimulation pulse to the electrode, and the carrier tissue facing surface including an adhesive region, the adhesive region being in contact with the external skin surface,   placing the percutaneous electrode in association peripheral motor nerves that innervate the muscle,   placing the carrier on an external skin surface so the adhesive region is in contact with the external skin surface,   coupling the percutaneous electrode to the carrier, and   operating the circuitry to determine whether the person has an innervated muscle which responds to electrical stimulation.   
     
     
         3 . A neuromuscular stimulation assembly comprising
 at least one percutanous electrode sized and configured for stimulation of a targeted neural or muscular tissue region,   a carrier sized and configured to be worn on the external skin surface, the carrier including a tissue facing surface,   programmable circuitry carried on-board the carrier configured to generate a stimulation pulse,   the carrier tissue facing surface including an adhesive region, the adhesive region being in contact with the external skin surface,   a power input bay carried on-board the carrier that is electrically coupled to the circuitry, and   an electrode connection element carried on-board the carrier that is electrically coupled to the circuitry, the electrode connection element being sized and configured to electrically couple the at least one electrode to the circuitry to apply the stimulation pulse to the tissue region.   
     
     
         4 . An assembly according to  claim 3   wherein the carrier tissue facing surface includes a return electrode, the return electrode being coupled to the circuitry and in contact with the external skin surface.   
     
     
         5 . An assembly according to  claim 3   further including a communication bay carried on-board the carrier that is electrically coupled to the programmable circuitry, the communication bay being sized and configured to establish a wireless communication link between the circuitry and an external device.   
     
     
         6 . An assembly according to  claim 1   wherein the circuitry is removable from the carrier and replaceable.   
     
     
         7 . An assembly according to  claim 1   wherein the return electrode is a transcutaneous electrode.   
     
     
         8 . An assembly according to  claim 3   wherein the programmable circuitry is removable from the carrier and replaceable.   
     
     
         9 . An assembly according to  claim 1   the carrier further including a power input bay sized and configured to hold a disposable battery for the circuitry that can be released and replaced for powering the circuitry,   instructions furnished by a clinician or caregiver or physician prescribing the release and replacement of the disposable battery according to a prescribed battery replacement regime, the prescribed battery replacement regime comprising the replacement of the disposable battery on a prescribed repeated basis similar to administering a pill under a prescribed pill-based medication regime, and   a supply of disposable batteries, each battery comprising a dose of power for the circuitry for administration according to the prescribed battery replacement regime.   
     
     
         10 . An assembly according to  claim 3   wherein the power input bay is sized and configured to hold a disposable battery for the circuitry that can be released and replaced for powering the circuitry,   the assembly further including instructions furnished by a clinician or caregiver or physician prescribing the release and replacement of the disposable battery according to a prescribed battery replacement regime, the prescribed battery replacement regime comprising the replacement of the disposable battery on a prescribed repeated basis similar to administering a pill under a prescribed pill-based medication regime, and   a supply of disposable batteries, each battery comprising a dose of power for the circuitry for administration according to the prescribed battery replacement regime.   
     
     
         11 . An assembly according to  claim 9  or  10   wherein the prescribed battery replacement regime comprises the replacement of the disposable battery repeated at least on about a daily basis.   
     
     
         12 . An assembly according to  claim 9  or  10   wherein the prescribed battery replacement regime comprises the replacement of the disposable battery repeated at least on about a weekly basis.   
     
     
         13 . A method for providing a neuromuscular stimulation function comprising
 providing a neuromuscular stimulation assembly comprising a carrier sized and configured to be worn by a user, the carrier including a tissue facing surface and a power input bay, the power input bay being sized and configured to hold a disposable battery for the circuitry that can be released and replaced for powering the circuitry, at least one percutaneous electrode extending from the carrier, circuitry carried on-board the carrier configured to generate a stimulation pulse to the electrode, and the carrier tissue facing surface including an adhesive region, the adhesive region being in contact with the external skin surface,   providing instructions furnished by a clinician or caregiver or physician prescribing the release and replacement of the disposable battery according to a prescribed battery replacement regime, the prescribed battery replacement regime comprising the replacement of the disposable battery on a prescribed repeated basis similar to administering a pill under a prescribed pill-based medication regime, and   providing a supply of disposable batteries, each battery comprising a dose of power for the circuitry for administration according to the prescribed battery replacement regime.   
     
     
         14 . A method according to  claim 13   wherein the prescribed battery replacement regime comprises the replacement of the disposable battery repeated at least on about a daily basis.   
     
     
         15 . A method according to  claim 13   wherein the prescribed battery replacement regime comprises the replacement of the disposable battery repeated at least on about a weekly basis.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.